We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

81 hedge funds and large institutions have $501M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

21% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 38

20% more capital invested

Capital invested by funds: $418M → $501M (+$83M)

11% more funds holding

Funds holding: 73 → 81 (+8)

17% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $2.83M

Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
18
Reduced
13
Closed
38
Calls
$2.35M
Puts
$2.83M
Net Calls
-$476K
Net Calls Change
-$7.87M

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$50.4M
2
SAM
Sandell Asset Management
New York
+$41.5M
3
OP
Omni Partners
United Kingdom
+$41.1M
4
JP Morgan Chase
JP Morgan Chase
New York
+$27.2M
5
OAM
Oxford Asset Management
United Kingdom
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$154M
2
MMH
Menora Mivtachim Holdings
Israel
-$24.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23.2M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$21.2M
5
Franklin Resources
Franklin Resources
California
-$19M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
101
Atika Capital Management
New York
– -$1.61M -54,000 Closed
CM
102
Crestline Management
Texas
– -$1.51M -50,468 Closed
ACA
103
Avoro Capital Advisors
New York
– -$1.33M -44,516 Closed
Victory Capital Management
104
Victory Capital Management
Texas
– -$1.26M -42,021 Closed
LOAMU
105
Lombard Odier Asset Management (USA)
New York
– -$1.2M -40,000 Closed
WMSA
106
Weiss Multi-Strategy Advisers
New York
– -$1.12M -37,500 Closed
Calamos Advisors
107
Calamos Advisors
Illinois
– -$804K -26,900 Closed
AG
108
Artal Group
Luxembourg
– -$748K -25,000 Closed
CLCM
109
Crawford Lake Capital Management
New Jersey
– -$452K -15,123 Closed
MWNA
110
Marshall Wace North America
New York
– -$396K -13,187 Closed
Connor, Clark & Lunn Investment Management (CC&L)
111
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$391K -13,075 Closed
MC
112
Menta Capital
California
– -$344K -11,500 Closed
TI
113
Trexquant Investment
Connecticut
– -$316K -10,582 Closed
NSEDCP
114
NJ State Employees Deferred Compensation Plan
New Jersey
– -$299K -10,000 Closed
HighTower Advisors
115
HighTower Advisors
Illinois
– -$226K -7,550 Closed
AIM
116
Advantage Investment Management
Iowa
– -$15K -500 Closed
AG
117
Advisor Group
Arizona
– -$7K -250 Closed
CG
118
Cutler Group
California
– -$3.68K -100 Closed
FWM
119
Focused Wealth Management
New York
– -$1K -32 Closed
1 2 3 4
5

NDRM Hedge Fund Activity: Q3 2017 in Review

81 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2017, worth a combined $501M — up 20% from $418M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new NDRM positions and 38 closed out — a net gain of 8 holders — while 18 added to existing stakes and 13 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $50.4M. The largest seller was Scopia Capital Management, cutting an estimated $154M.

  • 81 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2017, up from 73 in Q2 2017.
  • Funds reported $501M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2017, up 20% quarter-over-quarter.
  • 46 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2017 and 38 closed out, a net change of +8 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2017 was AQR Arbitrage, an estimated $50.4M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2017 was Scopia Capital Management, an estimated $154M sold.

Based on aggregated 13F filings for Q3 2017.